- Report
- July 2023
- 140 Pages
Global
From €4532EUR$4,949USD£3,861GBP
- Report
- April 2023
- 147 Pages
Global
From €4532EUR$4,949USD£3,861GBP
- Report
- May 2024
- 200 Pages
Global
From €3801EUR$4,150USD£3,238GBP
- Report
- May 2024
- 298 Pages
Global
From €7281EUR$7,950USD£6,202GBP
- Report
- February 2025
- 85 Pages
India
From €3205EUR$3,500USD£2,731GBP
From €3205EUR$3,500USD£2,731GBP
- Report
- December 2024
- 85 Pages
Spain
From €3205EUR$3,500USD£2,731GBP
- Report
- October 2024
- 87 Pages
Spain
From €3205EUR$3,500USD£2,731GBP
- Report
- August 2024
- 85 Pages
India
From €3205EUR$3,500USD£2,731GBP
- Report
- July 2024
- 82 Pages
Japan
From €3205EUR$3,500USD£2,731GBP
- Report
- April 2024
- 180 Pages
Global
From €4121EUR$4,500USD£3,511GBP
- Report
- November 2023
- 130 Pages
Asia Pacific
From €3663EUR$4,000USD£3,121GBP
- Report
- November 2023
- 171 Pages
Global
From €4121EUR$4,500USD£3,511GBP
- Report
- November 2023
- 77 Pages
France
From €3205EUR$3,500USD£2,731GBP
- Report
- November 2023
- 90 Pages
France
From €3205EUR$3,500USD£2,731GBP
- Report
- October 2023
- 183 Pages
Global
From €4121EUR$4,500USD£3,511GBP
- Report
- October 2023
- 177 Pages
Global
From €4121EUR$4,500USD£3,511GBP
- Report
- October 2023
- 88 Pages
India
From €3205EUR$3,500USD£2,731GBP
- Report
- October 2023
- 88 Pages
United States
From €3205EUR$3,500USD£2,731GBP
- Report
- October 2023
- 138 Pages
North America
From €3663EUR$4,000USD£3,121GBP

The Cancer Care market within the context of Oncology Drugs is a rapidly growing industry. It is composed of a variety of products and services, including drugs, diagnostics, and treatments. Oncology drugs are used to treat cancer, and they can be divided into two categories: targeted therapies and immunotherapies. Targeted therapies are designed to target specific cancer cells, while immunotherapies are designed to boost the body's own immune system to fight cancer. Both types of drugs are used to treat a variety of cancers, including breast, lung, and colorectal cancer.
The Cancer Care market is highly competitive, with many companies vying for market share. Companies in the market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. These companies are all involved in the development, manufacture, and marketing of oncology drugs. Additionally, there are many smaller companies that specialize in the development of new treatments and therapies. Show Less Read more